Infectious Diseases Archive — Page 3 of 13

December 11, 2025

Experts call for better adherence to guidelines for antiviral prescribing for children at higher risk of severe influenza

Researchers found a substantial gap between recommendations and real-world treatment practices in pediatric EDs (emergency departments) across the country.

December 1, 2025

Timothy Sterling receives $5.7 million to study tuberculosis transmission

Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.

November 17, 2025

VUMC’s Robert Carnahan named a 2025 Master Innovator

He is a translational scientist and antibody engineer who specializes in rapid therapeutic development for emerging infectious diseases.

November 11, 2025

Drug resistant infections are on the rise: Experts emphasize education, awareness

Teams at VUMC and Monroe Carell are focused on reaching more clinicians, patients and families through the Vanderbilt Antimicrobial Stewardship Program.

H. Keipp Talbot, MD, MPH
November 5, 2025

Keipp Talbot wins Anthony Fauci Courage in Leadership Award

Bestowed by the Infectious Diseases Society of America, the award “celebrates individuals who inspire and encourage others to make a difference.”

Cryogenic electron microscopy (cryo-EM) resolution of the structure of a respiratory syncytial virus fusion protein (shades of pink) bound to fragments of two antibodies (dark/light and blue/green) designed by the researchers’ protein language model, MAGE.
November 4, 2025

AI can speed antibody design to thwart novel viruses: study

While the study focused on development of antibody therapeutics against existing and emerging viral threats, the implications of the research are much broader.